欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	FI/H/1125/001
药品名称	Felodipin Sandoz 2,5 mg
活性成分	felodipine 2.5 mg
剂型	Prolonged-release tablet
上市许可持有人	Hexal A/S Edvard Thomsens Vej 14 2300 Copenhage Denmark
参考成员国 - 产品名称	Finland (FI)
互认成员国 - 产品名称	United Kingdom (Northern Ireland) (XI) Sweden (SE) Norway (NO)
许可日期	2008/10/10
最近更新日期	2022/06/09
药物ATC编码	C08CA02 felodipine
申请类型	TypeLevel1：[not specified] TypeLevel2：[not specified] TypeLevel3：[not specified] TypeLevel4：[not specified] TypeLevel5：[not specified]
附件文件下载	PAR \| 04_DE1158_1160_DC_Felodipin_final PARDate of last change:2023/01/24 Final Product Information \| common-final-spc-1158_1159-V013_012Date of last change:2019/11/22 Final Product Information \| common-final-label-1158_1159-V013_012Date of last change:2019/11/22 Final Product Information \| common-final-pl-1158_1159-V013_012Date of last change:2019/11/22 Final Labelling \| common final labop355Date of last change:2015/05/21 Final Labelling \| common final labop1158-60Date of last change:2015/05/21 Final Labelling \| common final labop1981Date of last change:2015/05/21 Final PL \| common final pil355Date of last change:2015/05/21 Final PL \| common final pil1158-60Date of last change:2015/05/21 Final PL \| common final pil1981Date of last change:2015/05/21 Final SPC \| common final spc355Date of last change:2015/05/21 Final SPC \| common final spc1158-60Date of last change:2015/05/21 Final SPC \| common final spc1981Date of last change:2015/05/21
市场状态	Positive